Comparison of three approaches to doxorubicin therapy: free doxorubicin, liposomal doxorubicin, and beta-glucuronidase-activated prodrug (HMR 1826). (Q54039771)
Jump to navigation
Jump to search
scientific article published in July 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Comparison of three approaches to doxorubicin therapy: free doxorubicin, liposomal doxorubicin, and beta-glucuronidase-activated prodrug (HMR 1826). |
scientific article published in July 2000 |
Statements
Comparison of three approaches to doxorubicin therapy: free doxorubicin, liposomal doxorubicin, and beta-glucuronidase-activated prodrug (HMR 1826). (English)
Woessner R
An Z
Li X
Hoffman RM
Dix R
Bitonti A
1 July 2000
20
4
2289-2296